SRXN1 Polyclonal Antibody, Cy3 Conjugated
Product Specifications
Background
Contributes to oxidative stress resistance by reducing cysteine-sulfinic acid formed under exposure to oxidants in the peroxiredoxins PRDX1, PRDX2, PRDX3 and PRDX4. Does not act on PRDX5 or PRDX6. May catalyze the reduction in a multi-step process by acting both as a specific phosphotransferase and a thioltransferase.
Synonyms
SRX; Npn3; SRX1; C20orf139; Sulfiredoxin-1; SRXN1
Gene ID
140809
Swiss Prot
Q9BYN0
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
45-137/137
Target
SRXN1
Clonality
Polyclonal
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human SRXN1
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
1ug/ul
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Prediction Reactivity
Dog, Cow, Pig, Horse, Chicken, Rabbit
Gene ID URL
140809
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC043065-500 1x 500 µL
PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker) (PC5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 